Vasyl Eisenberg

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection

M. Delorenzi, P. Knolle, Yiping Fan, 2019, Nature.

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

C. Cohen, T. Barliya, Shimrit Mayer, 2019, Journal of Immunotherapy for Cancer.

T-cells "à la CAR-T(e)" - Genetically engineering T-cell response against cancer.

C. Cohen, T. Barliya, V. Eisenberg, 2019, Advanced drug delivery reviews.

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

A. Porgador, G. Markel, C. Cohen, 2017, Front. Immunol..